- Home
- ALLK vs FONR Comparison
ALLK vs FONR Comparison
Compare ALLK & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- FONR
- Stock Information
- Founded
- ALLK 2012
- FONR 1978
- Country
- ALLK United States
- FONR United States
- Employees
- ALLK N/A
- FONR N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALLK Health Care
- FONR Health Care
- Exchange
- ALLK Nasdaq
- FONR Nasdaq
- Market Cap
- ALLK 22.5M
- FONR 95.7M
- IPO Year
- ALLK 2018
- FONR 1987
- Fundamental
- Price
- ALLK $0.25
- FONR $15.66
- Analyst Decision
- ALLK Hold
- FONR
- Analyst Count
- ALLK 3
- FONR 0
- Target Price
- ALLK $2.00
- FONR N/A
- AVG Volume (30 Days)
- ALLK 4.8M
- FONR 10.3K
- Earning Date
- ALLK 03-13-2025
- FONR 02-12-2025
- Dividend Yield
- ALLK N/A
- FONR N/A
- EPS Growth
- ALLK N/A
- FONR N/A
- EPS
- ALLK N/A
- FONR 1.42
- Revenue
- ALLK N/A
- FONR $102,006,089.00
- Revenue This Year
- ALLK N/A
- FONR N/A
- Revenue Next Year
- ALLK N/A
- FONR N/A
- P/E Ratio
- ALLK N/A
- FONR $10.92
- Revenue Growth
- ALLK N/A
- FONR 0.70
- 52 Week Low
- ALLK $0.23
- FONR $14.05
- 52 Week High
- ALLK $1.69
- FONR $24.05
- Technical
- Relative Strength Index (RSI)
- ALLK 28.77
- FONR 50.12
- Support Level
- ALLK $0.23
- FONR $15.12
- Resistance Level
- ALLK $0.26
- FONR $16.23
- Average True Range (ATR)
- ALLK 0.11
- FONR 0.34
- MACD
- ALLK -0.08
- FONR 0.04
- Stochastic Oscillator
- ALLK 1.62
- FONR 41.67
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.